An aggressive approach in converting resistant atrial fibrillation.
Bleyer
F L
FL
Saint Louis University Health Sciences Center, MO 63110-0250, USA.
Quattromani
A
A
Caracciolo
E A
EA
Bjerregaard
P
P
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D004554:Electric Countershock / Q000379:methods; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D011405:Propafenone / Q000627:therapeutic use; D019233:Retreatment; D017211:Treatment Failure
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D011405:Propafenone; D008790:Metoprolol; D001241:Aspirin